Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

509
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
509
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

451
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
451
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

496
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
496
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

370
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
370
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

545
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
545
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

332
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
332

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ringing the Alarm on Left-Ventricular and Biventricular Arrhythmogenic Cardiomyopathy.

JACC. Clinical electrophysiology·2026
Same author

Jailing of transvenous leads during transcutaneous tricuspid valve replacement: A perilous future?

HeartRhythm case reports·2026
Same author

Catheter ablation of epicardial premature ventricular complexes in patients with and without cardiac scar.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Successful Bipolar Radiofrequency Ablation for Intramural Premature Ventricular Complexes Protected by Transcatheter Aortic Valve.

JACC. Clinical electrophysiology·2026
Same author

Incidence of Worsening Aortic Regurgitation After Mapping and Ablation in the Aortic Cusps.

JACC. Clinical electrophysiology·2026
Same author

Multimodality Image Integration of FDG-PET and CMR Into Electroanatomic Mapping Identifies Electrophysiologic Signatures of Myocardial Inflammation in Cardiac Sarcoidosis.

JACC. Cardiovascular imaging·2026
Same journal

Beyond the Earliest Signal: A Three-Dimensional Perspective on the Substrate and Strategy of Outflow Tract PVC Ablation.

JACC. Clinical electrophysiology·2026
Same journal

Catheter Ablation of ARVC Ventricular Tachycardia With a Reverse R-Wave Pattern Break in Lead V2.

JACC. Clinical electrophysiology·2026
Same journal

Beyond QRS Duration in Cardiac Resynchronization Therapy.

JACC. Clinical electrophysiology·2026
Same journal

The High Road Is Clear: Reassuring Evidence for Aortic Valve Safety During Aortic Cusp Ablation.

JACC. Clinical electrophysiology·2026
Same journal

Intracardiac Electrograms During Left Bundle Branch Area Pacing Implantation.

JACC. Clinical electrophysiology·2026
Same journal

Marshall Bundle-Mediated Re-Entry After Combined Endo- and Epicardial PFA at the Mitral Isthmus Successfully Treated With VOMEI.

JACC. Clinical electrophysiology·2026
See all related articles

Related Experiment Video

Updated: Jan 24, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K

Premature Ventricular Complex-Induced Cardiomyopathy.

Rakesh Latchamsetty1, Frank Bogun1

  • 1Cardiac Arrhythmia Service, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.

JACC. Clinical Electrophysiology
|May 25, 2019
PubMed
Summary
This summary is machine-generated.

Frequent premature ventricular complexes (PVCs) can lead to reversible cardiomyopathy. Ventricular dyssynchrony is a key factor, and catheter ablation is the preferred treatment for PVC-induced cardiomyopathy (PIC).

Keywords:
cardiomyopathycatheter ablationpremature ventricular complexrisk factorssudden cardiac death

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.3K
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.3K

Related Experiment Videos

Last Updated: Jan 24, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.3K
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.3K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiomyopathy Research

Background:

  • Frequent premature ventricular complexes (PVCs) are linked to a reversible form of cardiomyopathy.
  • Ventricular dyssynchrony is increasingly recognized as a significant mechanism in PVC-induced cardiomyopathy (PIC).
  • Identifying risk factors beyond PVC burden is crucial for understanding PIC development.

Purpose of the Study:

  • To review the mechanisms and risk factors contributing to PVC-induced cardiomyopathy (PIC).
  • To discuss diagnostic approaches, including cardiac imaging, for identifying underlying structural heart disease.
  • To evaluate current management strategies, focusing on the efficacy and safety of catheter ablation versus pharmacotherapy for PIC.

Main Methods:

  • Review of existing literature on PVC-induced cardiomyopathy, animal models, and human clinical trials.
  • Analysis of diagnostic tools such as cardiac magnetic resonance imaging with delayed contrast enhancement.
  • Evaluation of outcomes from multicenter studies on catheter ablation and pharmacotherapy for PIC.

Main Results:

  • Ventricular dyssynchrony is a key component in the pathogenesis of PIC.
  • Thorough cardiac work-up is necessary to exclude other structural heart diseases.
  • Catheter ablation demonstrates high success rates and low complication rates, making it the preferred treatment for most PIC patients.

Conclusions:

  • Catheter ablation is the leading therapeutic option for managing PVC-induced cardiomyopathy.
  • Further research is needed to understand PIC in conjunction with other cardiomyopathies, its link to sudden cardiac death, and long-term effects.
  • Advances in ablation technology improve treatment for challenging PVC origins.